by Susan Johnson | Dec 1, 2011 | Clinical Trial, JBR Clinical Research, Pediatric, Vaccines
If you have a healthy 4 to 6 year old child, he/she may qualify for a clinical research study testing to protect against DTAP-IPV (diphtheria, tetanus and pertussis combined with the Inactivated Polio Virus Vaccine). Basic qualifications are: 4-6 years of age...
